Protective effects of rutin and quercetin against diazinon-induced toxicity in Wistar Rat Liver Authors: Mastoureh Naddafi, Thumu Udayabhaskararao Published: 2026 ABSTRACT AbstractDiazinon is extensively used as an insecticide or pesticide in agriculture. This insecticide can be absorbed by the human body through inhalation, oral ingestion, and skin, leading to human poisoning. The liver is the first organ affected by diazinon. The present study focused on the recovery of antioxidant biomarkers, including malondialdehyde (MDA), catalase (CAT), superoxide dismutase (SOD), and reduced glutathione (GSH), in addition to the acetylcholinesterase activity (AChE), using two flavonoids, namely rutin and quercetin, in the rat liver. The antioxidant properties of these two compounds are well-established. The results show that both rutin and quercetin at a dosage of 200 mg/kg can reduce the malondialdehyde and improve the other markers and acetylcholinesterase, with quercetin being more effective. Quercetin, owing to its superior antioxidant activity and higher bioavailability compared to rutin, effectively restored antioxidant enzyme activities (SOD, CAT, and GSH) and AChE levels in the liver of diazinon-poisoned rats to near control values. The current study suggests that quercetin is a more effective therapeutic agent than rutin for mitigating diazinon-induced hepatic oxidative stress and toxicity by scavenging ROS, inhibiting lipid peroxidation, and restoring redox homeostasis. Accordingly, quercetin can be considered as a potential treatment for diazinon poisoning. However, more animal, cellular, and clinical studies are necessary for prescribing and final approval for use in humans.Keywords: Quercetin, Diazinon, Rutin, Free radicals, Oxidative stressSubject terms: Biochemistry, Chemical biology, Drug discovery, Medical research Introduction Diazinon is an organophosphate molecule extensively used in agricultural practices as it effectively eradicates pests. However, using this insecticide has created some concerns about its toxicity towards other living organisms, including animals and humans1. Diazinon inhibits the acetylcholinesterase (AChE) enzyme, which results in the build-up of the neurotransmitter acetylcholine in the synapse and is responsible for neurological and systemic toxicity. Oscillatory convulsions, colonic spasms, breathing disorders, seizures, and, in extreme cases, death are signs that characterize diazinon’s toxicity in animals and humans. Because the use of this chemical poses a life-threatening consequence, efforts should be made to look for effective therapy in the case of diazinon poisoning2. Karimani et al.3 reported the toxic aspect of diazinon using various tests on male Wistar rats, which have established the physiological and biochemical changes in the animal body. Upon contact with diazinon, there is enhanced generation of reactive Oxygen species (ROS), lipid peroxidation (LPO), malondialdehyde (MDA), protein oxidation, and DNA damage, resulting in serious cellular damage. The impact is particularly detrimental in organ cells, including the liver, kidneys, and the brain. As a result, it has been evidenced that diazinon suppresses almost all the AChE and results in building up the content of acetylcholine, which leads to a mortal risk to the rat4,5. Therefore, this accumulation of overactive cholinergic receptors results in neurotoxic effects such as tremors, severe convulsions, paralysis, and fatal respiratory failure6. As a result, the previous studies insist on the importance of optimum therapeutic approaches to counteract diazinon toxicity. According to Thammachai and Sapbamrer7, the long-term effects of diazinon exposure have been observed to cause lasting neurological damages associated with learning disability and severe personality alterations. This neurotoxicity is based on diazinon’s propensity to cross the blood-brain barrier and cause direct, detrimental effects on the central nervous system8,9. Aside from the neurological consequences, diazinon has a systemic effect on about every organ system. Previous studies3 have revealed that it has hepatotoxic effects, which damage the liver; nephrotoxic effects, which interfere with proper kidney functioning; and cardiotoxic effects, which affect the desired functioning of the heart, on Wistar rats. These extensive toxic effects point to the significance of appropriating adequate therapeutic methods for the treatment of the far-reaching and even lethal impacts of Diazinon exposure. Therefore, the current study focuses on the toxic impact of diazinon on the Wistar Rat Liver and the possible therapeutic role of rutin and quercetin as natural bioflavonoids, which engage in antioxidant processes. Rutin belongs to the family of flavonoids, naturally derived components that exist in many plants, including buckwheat, citrus fruits, and apples. In general, it is widely recognized for its antioxidant activity, anti-inflammatory properties, its role in protecting blood vessels, and its positive impact on the cardiovascular system10. The chemical formula for Rutin is C27H30O16 (3), and the chemical structure is presented in Fig. 1a. The Chemical structure of (a) Rutin with chemical formula of C27H30O16, and (b) Quercetin with chemical formula of C15H10O7. The potent antioxidant, anti-inflammatory, and organ-protective effects of Rutin in both animal and cell culture models of toxicity, including organophosphate toxins, are well established in the literature11. This flavonoid works as a free radical scavenger to protect cells from oxidative stress by increasing the activities of necessary antioxidant enzymes, including catalase (CAT) and superoxide dismutase enzymes (SOD)10, reduced glutathione (GSH), lowering LPO products such as MDA, thus improving the endogenous antioxidant systems12 and offering protection against oxidative13. Besides, it has the potential to reactivate inhibited AChE enzymes. In animal experiments conducted on silver catfish, dietary supplementation of rutin has been demonstrated to counteract suppression of AChE activity resulting from organophosphate or other toxic exposures14. Rutin has been reported to possess the ability to decrease ROS production and the consequent toxic effect of oxidative damage when used in H₂O₂-treated bovine mammary epithelial cells15 in addition to the catfishes in separate studies16. Rutin exhibits therapeutic effects against diazinon-induced organophosphate toxicity and plays a significant role in the reactivation of both true acetylcholinesterase and pseudocholinesterase enzymes17. Rutin protects the organs and cells in several ways. It interacts with principal regulators of signaling pathways that control inflammation in the human body, thereby diminishing inflammation at the molecular level18–20. In addition, rutin modulates the expression of pro-inflammatory cytokines and inhibits the activation of critical transcription factors, contributing to the preservation of tissue integrity and prevention of inflammation-induced cellular damage across various organs, including the liver13. Quercetin is another flavonoid present in many fruits, vegetables, and grains, including onions, apples, berries, olive oil, red grape juice, and especially in saffron extract21. Quercetin aglycone has the chemical formula C15H10O7, a molecular weight of 302.236 g/mol, a density of 1.799 g/cm3, and a melting point of 316 °C. It is a yellow crystalline powder sensitive to moisture and insoluble in water but soluble in alkaline solutions. Quercetin possesses five phenolic hydroxyl groups at positions 3, 5, 7, 3’, and 4’, with the 3’,4’-dihydroxy catechol structure on ring B (Fig. 1b), playing a crucial role in its antioxidant properties. The double bond between carbons 2 and 3, conjugated with the carbonyl group at position 4, is also important for its antioxidant activity, as it stabilizes the resonance of the phenoxy radical22. Quercetin exhibits its overall antioxidant capacity based on the number and arrangement of hydroxyl groups and the conditions of conjugation, as evident from its structure. Quercetin donates a hydrogen atom from its hydroxyl group and stabilizes the resulting phenoxy radical through the delocalization of electrons within the aromatic structure. As an antioxidant, it directly scavenges free radicals. Quercetin controls enzymes that generate inflammation and lead to cell death. Like rutin, quercetin has antioxidant and anti-inflammatory activity22. Quercetin controls enzymes that generate inflammation and lead to cell death. It also inhibits enzymes such as ornithine decarboxylase, protein kinase, and calmodulin23,24. Like rutin, quercetin has antioxidant and anti-inflammatory activity22. Moreover, quercetin exhibits anti-prostaglandin, anti-inflammatory, anti-arrhythmic, anti-hypertensive, antiplatelet, and anti-atherosclerotic effects28. Quercetin is effective in managing and treating diabetic neuropathy, hyperglycemia, and exhibiting antimicrobial effects. Quercetin is a plant pigment and possesses anti-cancer properties. Due to its bronchodilatory effects, it can also be useful in treating asthma. One of its significant medicinal applications is in treating prostate inflammation and chronic infections. In addition, quercetin penetrates the blood-brain barrier and has a neuroprotective effect23,24. Epidemiological studies indicate that flavonoid-rich foods, such as vegetables, contribute to increased longevity and reduced cardiovascular disease risk. The advantages of quercetin are its distinct features, empowering it to increase AChE activity and reduce apoptosis, making it particularly effective in mitigating the potential neurotoxicity effects25. In summary, quercetin and its glycosylated derivatives, such as quercetin-3-monoglycoside and quercetin-4-O-monoglycoside, exhibit anti-prostaglandin, anti-inflammatory, anti-arrhythmic, anti-hypertensive, anti-cancer, and antiviral effects26. As it is presented, the toxic effects of diazinon on animals have been well documented, with substantial evidence demonstrating its ability to induce oxidative stress, neurotoxicity, and damage to vital organs, particularly the liver28. Rutin and quercetin, as bioactive flavonoids, have shown protective effects against various forms of toxicity, supporting their potential therapeutic relevance. However, despite these promising properties, studies specifically addressing their protective and therapeutic effects against diazinon-induced hepatotoxicity in animal models remain limited. This gap underscores the need for further investigation under physiologically relevant conditions. Therefore, the present study aims to evaluate the protective and therapeutic effects of rutin and quercetin on liver injury in diazinon-exposed Wistar rats. Methodology Animal details and determination of lethal dose Male 8-week-old Wistar rats, weighing 200–250 g and of appropriate age, purchased from Chengdu Dashuo Experimental Animal Co., Ltd., were divided into eight groups of six and housed in their respective cages. The animals were kept for one week without any injections to allow them to acclimate to the new environment. All animal procedures were approved by the Institutional Animal Ethics Committee (Approval No: E15041155) and conducted in accordance with international guidelines. To inject the right amount of the poison, the LD50 (Lethal Dose required to reduce the live animal population by 50%) of the diazinon was initially defined. Diazinon was bought from Zhejiang Rayfull Chemicals Co with 95% purity. LD50 assay was conducted to evaluate the cytotoxic effects of diazinon on rats. The rats were housed in a controlled animal laboratory, and varying doses of diazinon (35, 55, 85 mg/kg) were administered intraperitoneally to three separate groups. Once the number of surviving rats was reduced by half, the LD50 was determined using the control group as a reference. Table 1 illustrates the dose-response data, showing the relationship between diazinon dose and viability, with the LD50 calculated to be 57.7 mg/kg. Table 1Calculation of the LD50. A total of 9 rats have been used to calculate the LD 50. The value of LD50 was interpolated as equal to 57.7 mg/kg.Diazinon dose (mg/Kg)Mortality (%)3533% (3 rats)5545% (4 rats)85100% (9 rats) Calculation of the LD50. A total of 9 rats have been used to calculate the LD 50. The value of LD50 was interpolated as equal to 57.7 mg/kg. Experimental animal grouping In this study, sixty rats were assigned to ten groups (1–10), with six (6) rats per group. Groups 2, 5–10 were exposed to Diazinon while groups 1, 3, and 4 were not. Diazinon (57.7 kg/mg) (Zhejiang Rayfull Chemicals Co., with 95% purity) was dissolved in normal saline, and 0.5 mL was injected into each rat. Fifteen minutes later, 1 mL each of Rutin (Sigma-Aldrich, dissolved in 1.26% sodium bicarbonate solution) and Quercetin with 95% purity (Sigma-Aldrich) (dissolved in 20% hydroxypropyl-β-cyclodextrin (HP-β-CD) (Sigma-Aldrich) in sterile saline) was injected according to the grouping. All injections were done intraperitoneally. The grouping is suggested below. Group 1 (Control) – normal saline. Group 2 Diazinon solution. Group 3 200 mg/kg Rutin only. Group 4 200 mg/kg Quercetin only. Group 5 Diazinon + 50 mg/kg Rutin. Group 6 Diazinon + 100 mg/kg Rutin. Group 7 Diazinon + 200 mg/kg Rutin. Group 8 Diazinon + 50 mg/kg Quercetin. Group 9 Diazinon + 100 mg/kg Quercetin. Group 10 Diazinon + 200 mg/kg Quercetin. The details of all the groups are presented in Table 2. Table 2The details of the studied group.Group noGroup nameInjected substanceDosage1ConrodNormal saline----2DZNDiazinon+ normal saline57.7 mg/kg (LD50)3Ru 200Rutin dissolved in 1.26%sodium bicarbonate solution200 mg/kg4Qu 200Quercetin 20%hydroxypropyl-β-cyclodextrin(HP-β-CD) in sterile saline200 mg/kg5DZN + Ru 50Diazinon+ Rutin solutionDZN (LD 50), Ru (50 mg/Kg)6DZN + Ru 100Diazinon + Rutin solutionsDZN (LD 50), Ru (100 mg/Kg)7DZN + Ru 200Diazinon + Rutin solutionsDZN (LD 50), Ru (200 mg/Kg)8DZN + Qu 50Diazinon + Quercetin solutionsDZN (LD 50), Qu (50 mg/Kg)9DZN + Qu 100Diazinon + Quercetin solutionsDZN (LD 50), Qu (100 mg/Kg)10DZN + Qu 200Diazinon + Quercetin solutionsDZN (LD 50), Qu (200 mg/Kg) The details of the studied group. Rutin dissolved in 1.26% sodium bicarbonate solution Quercetin 20% hydroxypropyl-β-cyclodextrin (HP-β-CD) in sterile saline Acute toxicity was induced in the rats using diazinon at LD50, and after a 15-minute interval, the treatment with rutin was initiated. The 15-minute time was selected for a therapeutic intervention scenario in which antioxidant compounds were administered shortly after a toxic insult to assess their protective and mitigating effects. This time is sufficient for diazinon to be absorbed and reach systemic circulation, initiating oxidative stress, while still no permanent damage occurs to the organs. This provides an opportunity for the compounds to counteract the early toxic effects before irreversible damage occurs. The selected time range is used in previous studies investigating post-exposure antioxidant therapy in organophosphate toxicity models27. Twelve hours post-treatment, rats were euthanized under deep isoflurane anesthesia (Sigma-Aldrich) using a precision vaporizer, followed by cervical dislocation. Liver tissues were then excised, washed with 0.25 M mannitol (Sigma-Aldrich), homogenized in Tris buffer (pH 7.4, Sigma-Aldrich), and centrifuged (Eppendorf 5804 R, Germany) at 5000 rpm for 5 min. The enzymatic activity was then assessed. The enzymes and other indicators were measured 12 h after poison injection to capture the early-to-intermediate phase of oxidative stress and cholinergic disruption following acute diazinon exposure. In organophosphate toxicity, AChE inhibition occurs rapidly, often within minutes, while other biochemical effects, such as LPO (malondialdehyde, MDA), depletion of antioxidant enzymes including CAT, SOD, and GSH levels, change over several hours. Previous studies in rats have demonstrated that maximum oxidative stress markers and remarkable changes in antioxidant defenses often appear within 6–24 h after acute organophosphate poisoning28,29. A 12-hour time period was selected as a representative time to evaluate both the inhibitory effect on AChE and the early oxidative damage before compensatory recovery mechanisms dominate. The number of experimental replicates was n = 6 for each group. Acetylcholinesterase activity measurement In animals, there are two types of cholinesterase enzymes: Pseudocholinesterase (butyrylcholinesterase, BuChE), which is found in the serum (plasma), liver, heart, pancreas, and white matter of the brain, and hydrolyzes butyrylcholine more efficiently than acetylcholine; and true acetylcholinesterase, which present in higher concentrations in red blood cells, the gray matter of the nervous system, skeletal muscles, and endocrine glands. Although BuChE is the predominant form in liver tissue, AChE plays a critical role in cholinergic neurotransmission and is directly involved in the toxic mechanism of organophosphate compounds such as Diazinon. Inhibition of AChE leads to the accumulation of acetylcholine and the onset of cholinergic symptoms. In contrast, BuChE is considered a secondary biomarker and can be influenced by various physiological and pathological conditions. Therefore, in the present study, AChE was selected as the primary biomarker to evaluate the toxic effects of diazinon and the therapeutic potential of rutin and quercetin. To evaluate AChE activity in diazinon-poisoned rats, the enzyme-linked immunosorbent assay (ELISA) method was employed. The centrifuged mixture was collected and analyzed for AChE activity via ELISA. Homogenized live tissues were first added to ELISA plates coated with antibodies specific to AChE. After incubation and the necessary washing steps, a secondary antibody conjugated with horseradish peroxidase (HRP) (Sigma-Aldrich) was added to each well. Finally, an enzymatic substrate was added, and optical absorbance was measured at 450 nm to determine AChE activity in the samples. The enzyme activity in diazinon-poisoned rats and treated rats was compared and analyzed to assess the therapeutic efficacy of treatment. Malondialdehyde level measurement Lipid peroxidation, at its core, is a chain reaction fueled by radicals that tames down the integrity of lipids within membranes. LPO begins when radicals remove hydrogen atoms from methylene groups within unsaturated fatty acids. This leads to the formation of lipid radicals, which then rearrange themselves into conjugated dienes. These unstable molecules then immediately scavenge oxygen from the air, forming lipid peroxyl radicals (LOO•). The peroxyl radicals continue the chain reaction by removing hydrogen atoms from other lipid molecules, thereby maintaining the chain reaction. Ultimately, after several cycles, lipids are damaged, leading to cellular and membrane damage. Malondialdehyde (MDA) is a stable secondary end product formed during the decomposition of lipid hydroperoxides in LOP, which is measured in our study. The MDA detection kit (Cat# BC0025, Beijing Solarbio Science & Technology Co., Ltd) was used to measure the MDA. The kit uses a micro-scale method that depends on the reaction of malondialdehyde (MDA) with thiobarbituric acid (TBA) under acidic and high-temperature conditions to form a pink-red trimethine compound that has a maximal absorption wavelength of 532 nm. Before the test, the samples were prepared appropriately. A fresh working solution was also prepared by dissolving the reagent powder in the reagent solution. The test involves mixing the sample with the MDA detection working solution and reagent, followed by incubation for 60 min. The samples were then cooled, centrifuged, and the absorbance was measured at 532 nm and 600 nm using a 96-well microplate reader. The MDA content was calculated using the formula. ∆A is the corrected absorbance. For a 96-Well plate k = 53.763. F = 1 is a dilution factor, and W is the sample weight (g). Superoxide dismutase activity measurement Superoxide dismutase is an antioxidant enzyme that protects cells and tissues against damage caused by reactive oxygen species. In the present study, SOD activity was measured to evaluate the effects of the toxin and the treatment on oxidative status. SOD Activity Assay Kit (BC5165, Beijing Solarbio Science & Technology Co., Ltd) was used to measure SOD activity. The kit uses a colorimetric method for the measurement of SOD activity by evaluating its ability to inhibit the reduction of WST-1 (water-soluble tetrazolium salt) by superoxide anions (O2−) through a xanthine/xanthine oxidase reaction system. The two important reagents, Reagent 2 (Xanthine Oxidase) and Reagent 4 (WST-1), were freshly prepared by diluting them with distilled water. The test involved setting up four different reaction tubes for each sample, which were then incubated at 37 °C for 30 min and measured for absorbance at 450 nm. The activity of SOD was measured using the following method. First, inhibition percentage was calculated as , where and . The activity of SOD was calculated by using the formula: , divided by sample weight W(g), F is the dilution factor F = 1. Catalase activity measurement Catalase is a major antioxidant enzyme that converts hydrogen peroxide into water and oxygen. It protects liver cells from oxidative stress. Measuring the activity of CAT in diazinon-exposed individuals helps estimate the level of oxidative stress. The CAT activity assay kit (BC0205, Beijing Solarbio Science & Technology Co., Ltd) was used. This assay relies on the fact that hydrogen peroxide (H₂O₂) has an absorbance peak at 240 nm, which is destroyed by catalase. So, the homogenized tissue was mixed with a working solution containing H₂O₂, and the change of the absorbance at 240 nm was monitored over time and calculated as (). The used equation was , where is the total reaction volume (L), ε is the molar extinction coefficient of H2O2 (43.6 L/mol cm), d is the path length (cm), T is the reaction time (min), and the sample quantity is W×(Vsample/Vextraction) (g). Then the CAT was calculated as . The F is the normalization factor, and W is the sample weight (g). Reduced glutathione measurement Reduced glutathione is a critical intracellular antioxidant that scavenges ROS to maintain cellular redox balance. The measurement of GSH levels in diazinon-treated test subjects helps to assess the depletion of antioxidant reserves and the therapeutic effectiveness of rutin and quercetin treatments. GSH Level detection kit (BC1175, Beijing Solarbio Science & Technology Co., Ltd) was used. The kit determines GSH value by reacting it with DTNB (Ellman’s reagent) to produce TNB, which absorbs at 412 nm. The homogenized tissue was reacted with Reagent 1 to precipitate the protein, and then centrifuged. A standard curve of GSH concentrations was created by preparing a series of diluted solutions of the supplied standard solution to produce concentrations of 25–300 µg/mL. To perform this assay, 20 µL of the sample was mixed with 140 µL of Reagent 2 and 40 µL of Reagent 3. This mixture was incubated at room temperature for 2 min. The reaction mixture’s absorption at 412 nm was read to determine the absorption of the sample, standard solution, and a blank. This absorption value was then subtracted from the absorption value of each sample and standard solution to determine ΔA. ΔA values were calculated as and . The GSH level in each sample was determined by using the standard curve to determine the sample’s GSH concentrations by using the standard curve’s equation to solve for x as . Where m is the slope and b is the y-intercept of the standard curve. The GSH content in each sample was then calculated as , where W is the sample weight (g). Statistical analysis GraphPad Prism 6 software was used to analyze the data and present the results as mean ± SD. A one-way analysis of variance (ANOVA) was applied to assess statistical significance, with a threshold set at P < 0.001 for all measurements. The diazinon group shows a significant difference from the control group (P < 0.001). All the treatment groups show significant improvement compared to the diazinon group (P < 0.001). However, the difference between the routine and quercetin treatment was not statistically significant for certain parameters (e.g., MDA and SOD). Results In the present study of diazinon toxicity, measuring AChE, MDA, SOD, CAT, and GSH enables evaluation of oxidative stress and assessment of how treatments with rutin and quercetin protect and restore the antioxidant defense system. The effect of rutin and quercetin on acetylcholinesterase Figure 2 represents the AChE enzyme activity in diazinon-poisoned rats treated with rutin and quercetin. The control group, which received only normal saline, is depicted with a white background. Injection of 200 mg/kg rutin shows minimal change relative to the control group, indicating it is not toxic at this dosage. By injecting diazinon, the enzyme activity reduced sharply to 1.1 U/g tissue. The treatment using rutin was not very effective with a 50 mg/kg dosage, but increasing the dosage to 200 mg/kg restored enzyme activity to 1.8 U/g tissue, as shown in Fig. 2a. Although increasing the dosage shows an upward trend in recovering the AChE, at the highest dosage, it is still 0.5 U/g tissue smaller than the control group. The effect of rutin and quercetin treatment on acetylcholinesterase enzyme activity. The diazinon-poisoned rats were treated with 50 and 100, and 200 mg/kg of (a) rutin and (b) quercetin, and the AChE enzyme activity was measured. Data show the mean value ± Standard Error of the Mean (S.E.M), (n = 6). ***shows significant change, p < 0.001, compared with the control group, +++ shows significant change, p < 0.001, compared with diazinon. The group names are described in the text. In the graph, DZN represents diazinon, Ru represents rutin, and Qu represents quercetin. Quercetin exhibits better performance in inhibiting the toxic effects of diazinon compared to rutin (Fig. 2b). 200 mg/kg quercetin slightly improved the AChE compared to the control group and showed no toxicity. Injecting quercetin of 50 mg/kg dosage into the rats recovered the AChE activity to 1.4 U/g tissue. By increasing the dosage to 100 and 200 mg/kg, the AChE activity increased to 1.8 and 2.1 U/g tissue, respectively. The results show that the most effective treatment was achieved by using a 200 mg/kg dosage of quercetin, which recovered the enzyme activity to approximately that of the non-poisoned cases (control group). Quercetin has significantly better performance than rutin in AChE recovery (P < 0.001). The effect of rutin and quercetin on malondialdehyde (MDA) Figure 3 demonstrates the changes in the levels of malondialdehyde (nmol/g tissue) in the livers of rats after treatment with rutin and quercetin. The control group, which was given only a saline solution, had the lowest level of MDA with 10.7 nmol/g, indicating a normal LPO level. Injection of 200 mg/kg rutin and quercetin shows minimal change relative to the control group, indicating it is not toxic at this dosage. After treatment with diazinon, the MDA level increased to 15.2 nmol/g, indicating oxidative stress. The effect of rutin and quercetin treatment on Malondialdehyde (MDA) activity. The diazinon-poisoned rats were treated with 50 and 100, and 200 mg/kg of (a) rutin and (b) quercetin, and the MDA level was measured. Data show the mean value ± Standard Error of the Mean (S.E.M), (n = 6). ***shows significant change, p < 0.001, compared with the control group, +++ shows significant change, p < 0.001, compared with diazinon. The group names are described in the text. In the graph, DZN represents diazinon, Ru represents rutin, and Qu represents quercetin. The lowest dose of rutin, which is 50 mg, caused a slight reduction in the level of MDA to 14.4 nmol/g, indicating that the compound did not really help in the treatment. Increasing the dose of rutin to 100 and 200 mg/kg decreased the MDA level further to 13.1 nmol/g and 12.6 nmol/g, respectively. This shows that the protective effect of rutin increases with increasing dosage. Quercetin, on the other hand, provided a greater degree of protection against oxidative stress induced by diazinon. When 50 mg/kg quercetin was administered, the level of MDA decreased to 13.8 nmol/g. Increasing the dose of quercetin to 100 and 200 mg/kg decreased the MDA level further to 12.8 and 11.8 nmol/g, respectively. This brings the MDA level close to the control group, indicating a good degree of protection against oxidative damage caused by diazinon. The ability of quercetin to restore the level of MDA to normal is better than that of rutin, however it is not statistically significant (P > 0.05). The effect of rutin and quercetin on Superoxide dismutase Figure 4 depicts the result of the effects of exposure to diazinon and treatment using rutin and quercetin on SOD activity (U/g tissue) in liver tissues. The control group showed the highest activity of 1686 U/g for SOD. 200 mg/kg rutin injected into the healthy rats causes a slight decrease in the SOD activity, which is not statistically significant compared to the control group. When exposed to diazinon, it is evident that there is a significant reduction in SOD activity, recorded at 1280 U/g. This shows a significant decline of 24% compared to the control (p < 0.001). This clearly indicates that diazinon has a significant inhibitory effect on antioxidant defense mechanisms. The effect of rutin and quercetin treatment on Superoxide dismutase activity. The diazinon-poisoned rats were treated with 50 and 100, and 200 mg/kg of (a) rutin and (b) quercetin, and the SOD level was measured. Data show the mean value ± Standard Error of the Mean (S.E.M), (n = 6). ***shows significant change, p < 0.001, compared with the control group, +++ shows significant change, p < 0.001, compared with diazinon. The group names are described in the text. In the graph, DZN represents diazinon, Ru represents rutin, and Qu represents quercetin. At a dose of 50 mg/kg of rutin, an improvement in SOD activity (1406 U/g) was observed compared with the diazinon group (9.8% improvement). By increasing the dosage to 100 and 200 mg/kg, a corresponding increase in SOD activity to 1502 U/g and 1575 U/g was observed, respectively. This shows an improvement of 17.3% and 23.0%, respectively, compared to the diazinon group. While still SOD activity is not fully recovered to the control group value. Qu 200 group induced a slight decrease in SOD activity, considering quercetin as a non-toxic agent for rats. Quercetin has slightly improved SOD activity compared to rutin. At a dosage of 50 mg/kg, SOD activity (1448 U/g) improved by 13.1% compared to the diazinon group. Using 100 mg/kg of quercetin increased the activity of SOD to 1580 U/g. This shows an improvement of 23.4% compared to the control group. By injecting a higher dosage (200 mg/kg), a corresponding increase in activity for SOD to 1600 U/g was observed. This shows almost a 25.0% improvement compared to the rat purely exposure to diazinon. However, it is of 5.1% smaller than the control group. The difference between quercetin and rutin in recovering the SOD is not statistically significant. Considering the statistical analysis, P < 0.001 for all treatment groups compared to the diazinon group, the results show significant improvements in SOD activity by rutin and quercetin treatments. The effect of rutin and quercetin on Catalase activity Figure 5 shows how the catalase activity (U/g tissue) in rat liver samples changed after exposing the animals to diazinon and treatment with rutin and quercetin. CAT activity in the control group was 183.3 U/g, as in a healthy liver. The pesticide diazinon caused a significant drop in CAT activity to 91.6 U/g (P < 0.001). This result indicates an increase in the free radicals induced by the diazotization. Ru 200 and Qu 200 groups, which show the injection of 200 mg/kg rutin and quercetin separately in different groups, show a trivial effect on CAT activity, representing the non-toxic effect of these agents on the liver. The effect of rutin and quercetin treatment on Catalase activity. The diazinon-poisoned rats were treated with 50, 100, and 200 mg/kg of (a) rutin and (b) quercetin, and the CAT level was measured. Data show the mean value ± Standard Error of the Mean (S.E.M), (n = 6). ***shows significant change, p < 0.001, compared with the control group, +++ shows significant change, p < 0.001, compared with diazinon. The group names are described in the text. In the graph, DZN represents diazinon, Ru represents rutin, and Qu represents quercetin. Rutin treatment increased CAT activity, but the dosage of rutin is important. When a 50 mg/kg dose of rutin was used, the enzyme level increased to 143.5 U/g. Using the 100 mg/kg and 200 mg/kg doses of rutin increased CAT activity to 156.7 U/g and 165.2 U/g, respectively. Rutin shielded against diazinon toxicity; however, the maximum dose of rutin did not recover CAT activity to control group levels. Quercetin treatment demonstrated enhanced recovery effects. The CAT activity increased from 145.6 U/g at 50 mg/kg to 160.4 U/g at 100 mg/kg and 171.2 U/g at 200 mg/kg. Although quercetin exhibited higher catalase activity than rutin (171.2 vs. 165.2 U/g), the difference was not statistically significant (p > 0.05). Considering the statistical analysis, P < 0.001 for all treatment groups compared to the diazinon group, the results show significant improvements in CAT activity by rutin and quercetin treatments. The effect of rutin and quercetin on reduced glutathione Figure 6 shows the change in the levels of GSH (µmol/g tissue) in liver tissue after diazinon treatment and administration of rutin and quercetin. The control group showed the highest level of GSH at 3 µmol/g. In contrast, diazinon treatment caused a significant reduction (P < 0.001) in GSH levels to 1.2 µmol/g, indicating the depletion of antioxidant reserves in the liver. Ru 200 group shows a slight decrease in the GSH level, while Qu 200 shows a slight increase in the GSH level, which are not statistically significant compared to the control group, and represent the safety of the used dosage. The effect of rutin and quercetin treatment on reduced glutathione. The diazinon-poisoned rats were treated with 50, 100, and 200 mg/kg of (a) rutin and (b) quercetin, and the GSH level was measured. Data show the mean value ± Standard Error of the Mean (S.E.M), (n = 6). ***shows significant change, p < 0.001, compared with the control group, +++ shows significant change, p < 0.001, compared with diazinon. The group names are described in the text. In the graph, DZN represents diazinon, Ru represents rutin, and Qu represents quercetin. Rutin administration increased GSH levels in a dose-dependent manner. For example, at 50 mg/kg of rutin, the GSH level increased to 2.1 µmol/g. Further increases in the dose of rutin to 100 and 200 mg/kg increased the GSH levels to 2.3 µmol/g and 2.4 µmol/g, respectively. Although the levels of GSH in the rutin group were significantly increased compared to the diazinon group, the highest dose of rutin did not restore the levels of GSH to those of the control group. The levels of GSH in the quercetin group increased to 2.5 µmol/g at 50 mg/kg and further increased to 2.7 µmol/g and 2.8 µmol/g at 100 and 200 mg/kg of quercetin, respectively. At the highest dose, quercetin resulted in higher GSH levels compared with rutin (2.8 vs. 2.4 µmol/g), representing an approximately 17% higher value. This difference was statistically significant (p < 0.001). Considering the statistical analysis, P < 0.001 for all treatment groups compared to the diazinon group, the results show significant improvements in GSH activity by rutin and quercetin treatments, while quercetin had better performance. Discussion The present study demonstrates that administering diazinon to rats markedly reduced AChE, SOD, and CAT enzyme activity in addition to the hepatic GSH level, while MDA level increased, indicating enhanced oxidative stress. A clear dose–response relationship was observed for both rutin and quercetin, as increasing doses (50–200 mg/kg) progressively improved AChE activity and oxidative stress markers (MDA, SOD, CAT, and GSH). This trend is consistent with previous studies demonstrating that flavonoids exhibit dose-dependent antioxidant and protective effects30. For example, Khan et al.31 reported that quercetin shows dose-dependent antioxidant activity. Albrakati et al.32, shown that increasing doses of rutin increase its protection against oxidative damage32. However, Skibola and Smith33 asserted that at high doses, the adverse effects of flavonoids may outweigh the beneficial ones due to their behavior as free radical-generating pro-oxidants. No adverse effect was observed in the range of studied dosages. Underlying mechanisms of diazinon toxicity Inhibition of the AChE enzyme by diazinon leads to the accumulation of the neurotransmitter acetylcholine in the synapse29. Increasing the concentration of acetylcholine at receptor sites, leading to overstimulation of both peripheral and central cholinergic receptors30. Inhibition of the AChE enzyme naturally leads to muscarinic and nicotinic effects in the peripheral system, causing neurological and systemic toxicity. In vitro studies have shown that diazinon induces reactive oxygen species (ROS) production in cells, leading to cellular injury, as evidenced by increased lipid peroxidation products and depletion of endogenous antioxidants34,35, which are widely accepted indicators of ROS overproduction. In the liver, diazinon is bio-transformed into its active metabolite by cytochrome P450 enzymes, which are involved in the production of ROS, such as SOD and hydrogen peroxide. The overproduction of ROS leads to LPO via the removal of hydrogen atoms from polyunsaturated fatty acids of cellular membranes, producing lipid free radicals and secondary oxidative toxicity, such as MDA, which compromises membrane function and inhibits antioxidant enzymes such as SOD and CAT. In addition, LPO results in the depletion of GSH, thereby potentiating oxidative toxicity36. These mechanisms align with Jafari et al.37 results, who concluded that high doses of diazinon increase the levels of MDA and glutathione S-transferase, while simultaneously reducing GSH levels, lactate dehydrogenase, and AChE activity in the heart, brain, and spleen of rats. The present study similarly demonstrated that poisoning with the organophosphate toxin diazinon results in decreased AChE activity and GSH and increased levels of MDA in rats. Protective role of antioxidant agents in diazinon poisoning Shadnia et al.38 found that N-acetylcysteine improves AChE inhibition and the body’s antioxidant status in response to diazinon-induced organophosphate poisoning. By enhancing GSH levels, N-acetylcysteine effectively detoxifies free radicals generated by diazinon. Birdane et al.39 reported the effective treatment of diazinon poisoning by administering erdosteine. They reported that the underlying mechanism is improving the antioxidant defense system activity and reducing proinflammatory cytokine levels. Mehri et al.40, reported a successful treatment for diazinon poisoned rat with resveratrol, which significantly counteracted the oxidative stress and improved the antioxidant enzyme activities already reduced by diazinon. All the mentioned studies reported the effective treatment of the diazinon poisoned rat or cells using agents with antioxidant properties. Hepatoprotective effects of rutin and quercetin Under the influence of diazinon, the liver is typically the first organ to be subjected to severe oxidative stress41. In the present study, treatment with rutin and quercetin recovered all the mentioned biomarkers. Ping-Hu Pan et al.42 concluded that rutin exerts beneficial hepatoprotective effects against cholestatic liver injury. Rutin was found to alleviate bile duct obstruction while also reducing oxidative stress caused by the obstruction, leukocyte infiltration, and the production of pro-inflammatory cytokines. Shenbagam and Nalini43 discovered that rutin serves as a dietary antioxidant that mitigates alcohol-induced toxicity. It can greatly lower the levels of liver marker enzymes, like LPO, and greatly raise the activities of liver SOD, CAT, GSH, and glutathione peroxidase. In another study Abarikwu et al.44 reported that rutin restored activities of SOD, CAT, GSH-Px, and GST in liver homogenate in cadmium plus ethanol-exposed rats. The same observation is reported by Ismail et al.10 in the rat kidney exposed to gamma-irradiation. Rahmani et al.13 in a review paper reported that rutin reversed MDA elevation and restored GSH levels in hypercholesterolemic rats and increased SOD, CAT, GSH-Px activity, and decreased oxidative stress in different toxicity models. Quercetin’s effect in reducing oxidative stress is also observed in lindane toxicity45. Quercetin reduced MDA levels and improved the cellular antioxidant status by increasing the SOD, CAT, and GSH activity in rats. Quercetin treatment in a rat model of homocysteine-induced oxidative injury significantly reduced plasma MDA levels while increasing GSH and CAT levels and enhancing SOD activity, indicating its protective antioxidant effect46. Bao et al.47 showed that quercetin pretreatment reduced ROS and MDA levels, increased activities of antioxidant enzymes such as CAT, SOD, and GSH-Px, and exerted neuroprotective antioxidant activity against oxidative stress-induced cytotoxicity and apoptosis in PC-12 cells treated with hydrogen peroxide. The results of the present study are compatible with previous studies demonstrating the protective effects of quercetin and rutin against oxidative stress–induced liver injury. Comparative efficacy and proposed biochemical/molecular mechanisms of protection by rutin and quercetin Indeed, both rutin and quercetin are recognized as antioxidant agents that can scavenge ROS and other free radicals, reducing the diazinon toxicity effect13,48. Ademosun et al.49 revealed that quercetin and its glycosylated form, rutin, have effectively increased the AChE in rat brain homogenates. Our results, in alignment with the previous studies, show that compared to rutin, using quercetin at a dosage of 200 mg/kg is the most effective way to reduce the oxidative stress effect induced by diazinon poisoning and recover the MDA level and boost the antioxidant enzymes such as CAT, SOD, ACHE and GSH activity in rats’ liver to approximately its normal value. Quercetin demonstrated superior protective effects compared to rutin at the same dose (200 mg/kg), restoring the measured biomarkers closer to normal values. This difference can be explained by both pharmacokinetic and structural advantages. Quercetin is the aglycone form, whereas rutin is its glycosylated derivative (quercetin-3-O-rutinoside). The presence of a bulky sugar moiety increases molecular size and polarity in the case of rutin, making it less well absorbed in the intestine and reducing the ability of this compound to cross biological membranes50,51. Quercetin, due to its smaller size and sufficient lipophilicity, exhibits better permeability through membranes and higher bioavailability, thus easily reaching intracellular targets52. In addition, rutin requires enzymatic hydrolysis mediated by intestinal or hepatic β-glucosidases to liberate quercetin prior to exerting full antioxidant potency, a process that delays and reduces its biological effect compared with directly administered quercetin53. This superior activity of quercetin is attributed to its chemical structure. It possesses five hydroxyl groups, a conjugated double bond system (C2–C3 with C4 carbonyl), and a catechol moiety in the B ring. These features enable efficient electron delocalization, stabilization of phenoxyl radicals, strong free radical scavenging, and metal chelation54,55. In contrast, the bulky rutinose moiety at the 3-position of rutin creates steric hindrance, limiting its interaction with lipid membranes and enzymes56. Quercetin interrupts the chain of events of oxidative toxicity via the scavenging of ROS and the stabilizing effect on membrane lipids, thereby reducing LPO and the formation of MDA, and restoring the activities of antioxidant enzymes57. The higher uptake of quercetin into cells and its structure that stabilizes free radicals account for its better preservation of redox homeostasis and antioxidant enzymes compared with rutin. At the molecular level, by efficiently neutralizing ROS and chelating transition metal ions that catalyze Fenton reactions, quercetin (and to a lesser extent rutin) prevents the propagation of lipid peroxidation and the subsequent oxidative inactivation of antioxidant enzymes58. This action breaks the vicious cycle of oxidative stress triggered by diazinon bioactivation in hepatocytes and helps maintain cellular redox balance. Despite these findings, several limitations should be acknowledged. The study did not directly measure intracellular ROS levels or gene expression of antioxidant enzymes, and the proposed mechanisms are inferred from biochemical markers and literature. In addition, pharmacokinetic differences between rutin and quercetin were not experimentally evaluated. Future studies involving molecular assays (e.g., ROS quantification, gene/protein expression analysis, and enzyme kinetics) are needed to further validate the proposed mechanisms. To further strengthen and complete the mechanistic understanding of this work, future investigations will incorporate gene expression (RT-PCR) analysis and histopathological evaluation. Conclusion In the present study, the protective effects of rutin and quercetin on diazinon-induced liver toxicity in rats were investigated. Three different doses (50, 100, and 200 mg/kg) were used for both compounds. The results showed that the highest dose (200 mg/kg) was the most effective for both agents in recovering AChE enzyme activity. However, quercetin exhibited superior antioxidant properties compared to rutin and restored the levels of key biomarkers (CAT, SOD, AChE, and GSH) to near normal values. These findings suggest that quercetin is a more potent protective agent against diazinon-induced oxidative stress and liver damage, mainly through ROS scavenging, inhibition of lipid peroxidation, and preservation of antioxidant defense systems. Nevertheless, although rutin and quercetin showed promising results in this animal model, further pharmacological and clinical studies are required to determine the optimal dosage, frequency, and safety in humans before they can be recommended for clinical use. Author contributions Mastoureh Naddafi did all the experiments, analyzed the results, and wrote the manuscript.Udayabhaskararao is the supervisor who supervised the research and edited the manuscript. Funding This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Data availability Data will be provided upon a reasonable request. Competing interests The authors declare no competing interests. Declaration of generative AI technologies in the writing process During the preparation of this work, the authors made use of ChatGPT for refining sentence structure and improving clarity. After using the tool, the authors reviewed and edited the content, taking full responsibility for the final publication. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Contributor Information Mastoureh Naddafi, Email: mastooreh67@gmail.com. Thumu Udayabhaskararao, Email: uday@uestc.edu.cn. References Associated Data Data Availability Statement Data will be provided upon a reasonable request.